| Literature DB >> 33717098 |
Chao Hong1, Rong Jin1, Xiaoqiu Dai1, Xiaoming Gao1.
Abstract
Chronic graft-versus-host disease (cGVHD) is one of the most common reasons of late non-relapse morbidity and mortality of patients with allogeneic hematopoietic stem cell transplantation (allo-HSCT). While acute GVHD is considered driven by a pathogenic T cell dominant mechanism, the pathogenesis of cGVHD is much complicated and involves participation of a variety of immune cells other than pathogenic T cells. Existing studies have revealed that antigen presenting cells (APCs) play crucial roles in the pathophysiology of cGVHD. APCs could not only present auto- and alloantigens to prime and activate pathogenic T cells, but also directly mediate the pathogenesis of cGVHD via multiple mechanisms including infiltration into tissues/organs, production of inflammatory cytokines as well as auto- and alloantibodies. The studies of this field have led to several therapies targeting different APCs with promising results. This review will focus on the important roles of APCs and their contributions in the pathophysiology of cGVHD after allo-HSCT.Entities:
Keywords: allogeneic hematopoietic stem cell transplantation; antigen presenting cells; chronic graft versus host disease; immune regulation; immune tolerance
Mesh:
Year: 2021 PMID: 33717098 PMCID: PMC7943746 DOI: 10.3389/fimmu.2021.614183
Source DB: PubMed Journal: Front Immunol ISSN: 1664-3224 Impact factor: 7.561